Science · 2 views

U.S. approval of cheap, generic HIV prevention shot may boost global rollout

Source Summary Published 20h 04m ago Brief Under 1 min brief

Story intelligence

Coverage Single outlet Single-outlet story

Views 2 Community interest

Brief read Under 1 min brief 17 words

Summary

Indian company pledges to sell injectable lenacapavir in low- and middle-income countries for only $40 a year

Read original at Science.org

Coverage Context

Part of HIV coverage 73 tracked stories

Explore HIV View timeline

Phys.org50m ago1 view
When to move is key to mobile retailContinue reading
ScienceAlert1h ago1 view
Inca Mummies Reveal Drugs Used During Human SacrificeContinue reading
New Scientist1h ago1 view
Inca children were drugged before being sacrificedContinue reading
Phys.org2h ago4 views
Gas inside us could fight wound infections, moth study showsContinue reading

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page

HAPPENING NOW

U.S. approval of cheap, generic HIV prevention shot may boost global rollout

Coverage Context

More from Science